Israel Englander Penumbra Inc Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $378,994 - $492,690	-2,200 Reduced 9.4%	21,200 $3.82 Million
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $308,126 - $382,409	1,400 Added 6.36%	23,400 $5.22 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $3.63 Million - $5.2 Million	20,000 Added 1000.0%	22,000 $5.53 Million
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $7.98 Million - $10.1 Million	-29,400 Reduced 93.63%	2,000 $688,000
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $1.41 Million - $1.78 Million	6,400 Added 25.6%	31,400 $8.75 Million
Q4 2022 Feb 14, 2023	SELL	$151.88 - $228.5 $1.7 Million - $2.56 Million	-11,200 Reduced 30.94%	25,000 $5.56 Million
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $1.34 Million - $2.29 Million	11,100 Added 44.22%	36,200 $6.86 Million

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.39B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.